Login
$TNGX
$24.22 +$0.05 (0.21%) After hours

$TNGX SEC Filings

Filed On Filing
16 Nov 2026 SCHEDULE 13G/A
16 Nov 2026 SCHEDULE 13G/A
13 Nov 2026 Form 4: Crystal Adam, President, R&D

Received 5,000 shares by exercise or conversion ($14.6K) · Sold 5,000 shares ($125K)

09 Nov 2026 8-K: Results of Operations and Financial Condition

Promising Phase 1/2 data from combination study of vopimetostat plus daraxonrasib presented at 2026 ESMO Congress demonstrated 82% objective response rate (ORR) and 88% 9-month progression-free survival (PFS) rate in patients with 2L/3L ...

09 Nov 2026 10-Q
06 Nov 2026 SCHEDULE 13G/A
04 Nov 2026 Form 4: Crystal Adam, President, R&D

Received 5,000 shares by exercise or conversion ($14.6K) · Sold 5,000 shares ($112K)

04 Nov 2026 Form 4: Newcomb Jessica, Principal Accounting Officer

Sold 7,031 shares ($158K)

02 Nov 2026 144
23 Oct 2026 8-K: Regulation FD Disclosure; Other Events

Disclaimer and safe harbor statement Certain statements in this presentation may be considered forward-looking statements. All statements other than statements of historical fact are statements that could be deemed forward-looking statem...

05 Oct 2026 Form 4: Crystal Adam, President, R&D

Received 27,000 shares by exercise or conversion ($140K) · Sold 27,000 shares ($661K)

24 Sep 2026 Form 4: Newcomb Jessica, Principal Accounting Officer

Sold 8,200 shares ($199K)

22 Sep 2026 144
03 Sep 2026 Form 4: Crystal Adam, President, R&D

Received 27,000 shares by exercise or conversion ($140K) · Sold 27,000 shares ($604K)

14 Aug 2026 SCHEDULE 13G
14 Aug 2026 SCHEDULE 13G/A
14 Aug 2026 SCHEDULE 13G/A
14 Aug 2026 SCHEDULE 13G/A
14 Aug 2026 SCHEDULE 13G/A
12 Aug 2026 SCHEDULE 13G/A

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support